Liability Risk and Insurance

Tony Dowding

Document

Call for MRC assessment of Roaccutane

Questions about the Hoffmann-La Roche anti-acne drug Roaccutane (Accutane in the US) continue with a call to the Medical Research Council (MRC) for its reassessment.

The rest of this document is only available to i-law.com online subscribers.

If you are already a subscriber, click Log In button.